Identification of potential targets amenable to novel therapeutics to treat symptoms in primary biliary cholangitis

被引：0

作者：

Wetten, Aaron ^{[1
,2
]}

Barron-Millar, Ben ^{[2
]}

Ogle, Laura ^{[2
]}

Mells, George ^{[3
]}

Flack, Steven ^{[3
]}

Hegade, Vinod ^{[4
]}

Sandford, Richard ^{[3
]}

Kirby, John ^{[2
]}

Palmer, Jeremy ^{[2
]}

Brotherston, Sophie ^{[2
]}

Jopson, Laura ^{[1
,2
]}

Brain, John ^{[2
]}

Smith, Graham ^{[5
]}

Rushton, Steve ^{[6
]}

Jones, Rebecca L. ^{[4
]}

Rushbrook, Simon ^{[7
]}

Thorburn, Douglas ^{[8
]}

Ryder, Stephen ^{[9
]}

Hirschfield, Gideon ^{[10
,11
]}

Jones, David ^{[1
,2
]}

Dyson, Jessica ^{[1
,2
]}

机构：

[1] Newcastle Freeman Hosp, Newcastle Upon Tyne, England

[2] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, England

[3] Univ Cambridge, Dept Human Genet, Cambridge, England

[4] St James Hosp, Liver Unit, Leeds, England

[5] Newcastle Univ, Bioinformat Support Unit BSU, Newcastle Upon Tyne, England

[6] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, England

[7] Norwich Med Sch, Univ Dept Hepatol, Norwich, England

[8] Royal Free Hosp, Liver Unit, London, England

[9] NIHR Nottingham Biomed Res Ctr, Queens Med Ctr, Nottingham, England

[10] Queen Elizabeth Hosp Birmingham, Birmingham, England

[11] Univ Toronto, Toronto Ctr Liver Dis, Toronto, ON, Canada

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-331

引用

页码：S411 / S412

页数：2

共 50 条

[1] Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets
Carbone, Marco
Milani, Chiara
Gerussi, Alessio
Ronca, Vincenzo
Cristoferi, Laura
Invernizzi, Pietro
JOURNAL OF HEPATOLOGY, 2020, 73 (04) : 965 - 966
[2] Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics
Patel, Amitkumar
Seetharam, Anil
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2016, 6 (04) : 311 - 318
[3] Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
Park, Ji-Won
Kim, Jung-Hee
Kim, Sung-Eun
Jung, Jang Han
Jang, Myoung-Kuk
Park, Sang-Hoon
Lee, Myung-Seok
Kim, Hyoung-Su
Suk, Ki Tae
Kim, Dong Joon
BIOMEDICINES, 2022, 10 (06)
[4] Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis
Probert, Philip M.
Leitch, Alistair C.
Dunn, Michael P.
Meyer, Stephanie K.
Palmer, Jeremy M.
Abdelghany, Tarek M.
Lakey, Anne F.
Cooke, Martin P.
Talbot, Helen
Wills, Corinne
McFarlane, William
Blake, Lynsay I.
Rosenmai, Anna K.
Oskarsson, Agneta
Figueiredo, Rodrigo
Wilson, Colin
Kass, George E.
Jones, David E.
Blain, Peter G.
Wright, Matthew C.
JOURNAL OF HEPATOLOGY, 2018, 69 (05) : 1123 - 1135
[5] IDENTIFICATION OF NOVEL BILIARY EPITHELIAL CELL BIOMARKERS IN PRIMARY BILIARY CHOLANGITIS (PBC)
Shimoda, Shinji
Harada, Kenichi
Nakamura, Minoru
Gershwin, M. Eric
HEPATOLOGY, 2019, 70 : 773A - 773A
[6] Targets and investigative treatments for primary biliary cholangitis
Ali, Ahmad H.
Carey, Elizabeth J.
Lindor, Keith D.
EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (10): : 1011 - 1020
[7] New treatments/targets for primary biliary cholangitis
Corpechot, Christophe
Poupon, Raoul
Chazouilleres, Olivier
JHEP REPORTS, 2019, 1 (03) : 203 - 213
[8] Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis
Ahn, Dong-Won
KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (05): : 246 - 256
[9] Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach
Mousa, Hani S.
Carbone, Marco
Malinverno, Federica
Ronca, Vincenzo
Gershwin, M. Eric
Invernizzi, Pietro
AUTOIMMUNITY REVIEWS, 2016, 15 (09) : 870 - 876
[10] Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives
Yang, Yanlei
Zhao, Robert Chunhua
Zhang, Fengchun
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10

← 1 2 3 4 5 →